Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D004569:Electroencephalography; D004958:Estradiol / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects; D008234:Lynestrenol / Q000009:adverse effects; D008535:Megestrol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009422:Nervous System Diseases / Q000139:chemically induced*; D009644:Norgestrel / Q000009:adverse effects
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003279:Contraceptives, Oral, Sequential; D003280:Contraceptives, Oral, Synthetic; D003692:Delayed-Action Preparations; D006908:Hydroxyprogesterones; D009644:Norgestrel; D004997:Ethinyl Estradiol; D004958:Estradiol; D005040:Ethynodiol Diacetate; D008656:Mestranol; D008535:Megestrol; D008234:Lynestrenol